Skip to main content
Christopher B. Hansen
( out of 655 reviews )

Christopher B. Hansen, MD

Languages spoken: English, French

Clinical Locations

Midvalley Health Center

Murray
801-581-2955

University of Utah Hospital

Dermatology, Area E
Salt Lake City
801-581-2955
  • Christopher B. Hansen, MD has specialized expertise in the evaluation and treatment of rheumatic skin diseases such as lupus erythematosus, dermatomyositis, and scleroderma. He is board certified in Dermatology. Dr. Hansen’s main clinical focus is the medical management of connective tissue diseases that involve the skin as well as common skin disorders such as acne, rashes, and skin cancer. Dr. Hansen runs the UVA-1 phototherapy program in the Department of Dermatology. UVA-1 phototherapy is primarily used to treat patients with sclerosing skin disorders like morphea.

    Board Certification

    American Board of Dermatology (Dermatology)

    Patient Rating

    5.0 /5
    ( out of 655 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 31, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr. Hansen has a great bedside manner. I felt listened to and that my concerns were taken seriously. I came away from my visit very impressed with Dr. Chris Hansen.

    October 30, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr Chris Hansen is awesome. Have seen him for several years and has always taken care of my dermatology issues. My adult special needs son had his first visit with him and Dr Hansen was wonderful. Very thorough first visit and addressed his concerns.

    October 29, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr. Hansen is always extremely thorough, patient and interested in making sure I have any and all questions answered. I appreciate his demeanor and willingness to take the time!

    October 29, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr. Hansen is so knowledgeable and helpful. You can tell he has your best interests in mind and includes you in decisions about care and treatment. He is thorough, making me feel confident I was heard and well taken care of.

    October 23, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    I have been Dr. Hansen's patient for years and I have enjoyed every moment. He's great at what he does.

    October 23, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr. Chris Hansen is very thorough and careful with checking my skin for problems. He addresses every concern I have and helps me to know if there is something I need to do. He is the best dermatologist I have ever been to!

    October 22, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr. Hansen is a wonderful physician. He is thorough, efficient, and kind.

    October 21, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    An excellent physician who I trust with my skin care needs.

    October 18, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Christopher B. Hansen is a great dermatologist. He is caring, helpful and makes me feel comfortable.

  • Christopher B. Hansen, MD has specialized expertise in the evaluation and treatment of rheumatic skin diseases such as lupus erythematosus, dermatomyositis, and scleroderma. He is board certified in Dermatology. Dr. Hansen’s main clinical focus is the medical management of connective tissue diseases that involve the skin as well as common skin disorders such as acne, rashes, and skin cancer. Dr. Hansen runs the UVA-1 phototherapy program in the Department of Dermatology. UVA-1 phototherapy is primarily used to treat patients with sclerosing skin disorders like morphea.

    Board Certification and Academic Information

    Academic Departments Dermatology -Primary
    Board Certification
    American Board of Dermatology (Dermatology)

    Education history

    Chief Resident Dermatology - University of Texas Southwestern Chief Resident
    Dermatology - University of Texas Southwestern Medical School Resident
    Internship Internal Medicine - University of Utah School of Medicine Intern
    Dermatology - University of Utah - Dermatology Research Fellow
    Professional Medical Medicine - University of Utah M.D.
    French - University of Utah B.A.

    Selected Publications

    Journal Article

    1. Hopkins ZH, Jimenez A, Taliercio VL, Clarke JT, Hansen CB, Hull CM, Rhoads JLW, Zone JJ, Sahni VN, Kean J, Secrest AM (2024). Skin-Related Quality of Life During Autoimmune Bullous Disease Course. JAMA Dermatol, 159(11), 1185-1194. (Read full article)
    2. Marcelus C, Jimenez A, Zussman J, Hansen CB, Sontheimer RD (2022). Questions raised by a case of adult-onset linear nodular scleroderma. Dermatol Online J, 28(5). (Read full article)
    3. Overbury RS, Stoddard GJ, Pupaibool J, Hansen CB, Lebiedz-Odrobina D (2021). The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers' opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle. BMC Health Serv Res, 21(1), 913. (Read full article)
    4. Beshay A, Zussman J, Hansen C (2020). Recurrent erythematous patch on the upper arm. JAAD Case Rep, 6(12), 1214-1216. (Read full article)
    5. Winchester D, Duffin KC, Hansen C (2012). Response to ustekinumab in a patient with both severe psoriasis and hypertrophic cutaneous lupus. Lupus, 21(9), 1007-10. (Read full article)
    6. Hansen CB, Dahle KW (2012). Cutaneous lupus erythematosus. Dermatol Ther, 25(2), 99-111. (Read full article)
    7. Gammon B, Hansen C, Costner MI (2011). Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus. J Am Acad Dermatol, 65(4), 717-721.e2. (Read full article)
    8. Lowe GC, Henderson CL, Grau RH, Hansen CB, Sontheimer RD (2011). A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol, 164(3), 465-72. (Read full article)
    9. Hansen CB, Callen JP (2010). Connective tissue panniculitis: lupus panniculitis, dermatomyositis, morphea/scleroderma. Dermatol Ther, 23(4), 341-9. (Read full article)

    Case Report

    1. Shah A, Bowen A, Hansen C (2020). Multifocal periungual granulation tissue related to ibrutinib therapy. JAAD Case Rep, 6(2), 149-151. (Read full article)

    Letter

    1. Westerdahl S, Hull CM, Clarke JT, Hansen CB, Rhoads JLW (2020). A single-center, retrospective record review of malignancy prevalence in patients with dermatomyositis with anti-transcription intermediary factor 1γ antibodies via line immunoassay versus immunoprecipitation. [Letter to the editor]. J Am Acad Dermatol, 84(2), 559-561. (Read full article)
    2. Gonzalez CD, Hansen C, Clarke JT (2019). Adverse cutaneous drug reactions with antimalarials in cutaneous lupus and dermatomyositis: A retrospective cohort study. [Letter to the editor]. J Am Acad Dermatol, 81(3), 859-860. (Read full article)